Myomo, Inc. (MYO)


+0.09 (+9.18%)
Symbol MYO
Price $1.07
Beta 0.902
Volume Avg. 0.49M
Market Cap 28.370M
Shares () -
52 Week Range 0.369-1.65
1y Target Est -
DCF Unlevered MYO DCF ->
DCF Levered MYO LDCF ->
ROE -106.10% Strong Sell
ROA -65.09% Strong Sell
Operating Margin -
Debt / Equity 3.64% Neutral
P/E -1.37 Sell
P/B 3.40 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest MYO news

Mr. Paul R. Gudonis
Medical Devices
American Stock Exchange

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.